There’s no truth to the link between innovative pharmaceuticals and the sustainability of healthcare spending. Most growth in both levels and rates of increases in healthcare spending is centred around increased utilization due to aging, less healthy populations, economic growth, and the growth in the prevalence of non-communicable diseases (utilization); the adoption of newer, better